1-6 of 6
Alan S. Gamis
Close
Sort by
Journal Articles

Prognostic impact of cooccurring mutations in FLT3 -ITD pediatric acute myeloid leukemia

Katherine Tarlock, Robert B. Gerbing, Rhonda E. Ries, Jenny L. Smith, Amanda Leonti, Benjamin J. Huang, Danielle Kirkey, Leila Robinson, Jack H. Peplinksi, Beverly Lange, Todd M. Cooper, Alan S. Gamis, E. Anders Kolb, Richard Aplenc, Jessica A. Pollard, Todd A. Alonzo, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2094–2103.
https://doi.org/10.1182/bloodadvances.2023011980
Published: 2024
Includes: Supplemental data
Journal Articles

Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia

Oussama Abla, Rhonda E. Ries, Tim Triche, Jr, Robert B. Gerbing, Betsy Hirsch, Susana Raimondi, Todd Cooper, Jason E. Farrar, Nathaniel Buteyn, Lauren M. Harmon, Hong Wen, Aniruddha J. Deshpande, E. Anders Kolb, Alan S. Gamis, Richard Aplenc, Todd Alonzo, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2024) 8 (8): 2005–2017.
https://doi.org/10.1182/bloodadvances.2023010805
Published: 2024
Includes: Supplemental data
Journal Articles

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis

Clinical Trials & Observations
Sara Zarnegar-Lumley, Todd A. Alonzo, Robert B. Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E. Ries, Jim Wang, Amanda Leonti, Matthew A. Kutny, Fabiana Ostronoff, Jerald P. Radich, Frederick R. Appelbaum, Era L. Pogosova-Agadjanyan, Kristen O’Dwyer, Martin S. Tallman, Mark Litzow, Ehab Atallah, Todd M. Cooper, Richard A. Aplenc, Omar Abdel-Wahab, Alan S. Gamis, Selina Luger, Harry Erba, Ross Levine, E. Anders Kolb, Derek L. Stirewalt, Soheil Meshinchi, Katherine Tarlock
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5941–5953.
https://doi.org/10.1182/bloodadvances.2022008282
Published: 2023
Includes: Supplemental data
Journal Articles

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes

Clinical Trials & Observations
Benjamin J. Huang, Jenny L. Smith, Yi-Cheng Wang, Kassra Taghizadeh, Amanda R. Leonti, Rhonda E. Ries, Yanling Liu, Pandurang Kolekar, Katherine Tarlock, Robert Gerbing, Erin Crowgey, Scott N. Furlan, Timothy I. Shaw, Kohei Hagiwara, Lisa Wei, Todd M. Cooper, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Jason E. Farrar, Timothy Triche, Jr, Todd A. Alonzo, Xiaotu Ma, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4963–4968.
https://doi.org/10.1182/bloodadvances.2021004965
Published: 2021
Includes: Supplemental data
Journal Articles

Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children’s Oncology Group

Clinical Trials & Observations
Karen M. Chisholm, Amy E. Heerema-McKenney, John K. Choi, Jenny Smith, Rhonda E. Ries, Betsy A. Hirsch, Susana C. Raimondi, Todd A. Alonzo, Yi-Cheng Wang, Richard Aplenc, Lillian Sung, Alan S. Gamis, Soheil Meshinchi, Samir B. Kahwash
Journal: Blood Advances
Blood Adv (2020) 4 (23): 6000–6008.
https://doi.org/10.1182/bloodadvances.2020002712
Published: 2020
Includes: Supplemental data
Journal Articles

Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report

Lisa Eidenschink Brodersen, Robert B. Gerbing, M. Laura Pardo, Todd A. Alonzo, Dana Paine, Wayne Fritschle, Fan-Chi Hsu, Jessica A. Pollard, Richard Aplenc, Samir B. Kahwash, Betsy Hirsch, Susana Ramondi, Denise Wells, E. Anders Kolb, Alan S. Gamis, Soheil Meshinchi, Michael R. Loken
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5050–5061.
https://doi.org/10.1182/bloodadvances.2020002070
Published: 2020
Includes: Supplemental data